Join
Live feed
·
INSIDERFilingvia Quantisnow
Voyager Therapeutics Inc. logo

President & CEO Sandrock Alfred sold $74,066 worth of shares (16,644 units at $4.45), decreasing direct ownership by 5% to 308,518 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VYGR (Voyager Therapeutics Inc.) and more on Quantisnow.